NM_000038.6:c.288T>A
Variant summary
Our verdict is Pathogenic. Variant got 19 ACMG points: 19P and 0B. PVS1PM2PP3PP5_Very_Strong
The NM_000038.6(APC):c.288T>A(p.Tyr96*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,852 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000038.6 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 19 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251468Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135912
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461852Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 727234
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Familial adenomatous polyposis 1 Pathogenic:3
- -
This variant is considered pathogenic. This variant creates a termination codon and is predicted to result in premature protein truncation. -
This sequence change creates a premature translational stop signal (p.Tyr96*) in the APC gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in APC are known to be pathogenic (PMID: 17963004, 20685668). This variant is present in population databases (rs376213437, gnomAD 0.0009%). This premature translational stop signal has been observed in individual(s) with attenuated familial adenomatous polyposis (AFAP) and colon polyps (PMID: 24549056, 26681312). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 181831). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:3
The APC p.Tyr96X variant was identified once in the literature in a cohort of individuals with familial adenomatous polyposis (Lagarde 2010). The total number of individuals in the study was not provided however, and the variant in this study had a different nucleotide change (c.288T>G) which resulted in the same change at protein level as the variant identified by our lab. The p.Tyr96X variant leads to a premature stop codon at position 96. This alteration would typically be predicted to result in a truncated or absent protein and loss of function; however, one study has demonstrated that for APC mutations closer to the 5’ terminus, an internal ribosome entry site is utilized to initiate translation at codon 184, resulting in a partially functional N-terminally truncated protein, which results in an attenuated phenotype (Heppner Goss 2002). In summary, based on the above information, this variant is classified as pathogenic. -
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 23159591, 26681312, 20685668, 30720243, 24549056) -
- -
Familial multiple polyposis syndrome Pathogenic:1
Variant summary: APC c.288T>A (p.Tyr96X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 4e-06 in 251468 control chromosomes. c.288T>A has been reported in the literature in multiple individuals affected with Familial Adenomatous Polyposis (example, Ibrahim_2014, Park_2022, Susswein_2016). These data indicate that the variant is very likely to be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 24549056, 34897210, 26681312). Four submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.Y96* pathogenic mutation (also known as c.288T>A), located in coding exon 3 of the APC gene, results from a T to A substitution at nucleotide position 288. This changes the amino acid from a tyrosine to a stop codon within coding exon 3. This alteration has been identified in several familial adenomatous polyposis (FAP) and colorectal cancer (CRC) patients (Ambry internal data; Ibrahim A et al. Eur. J. Hum. Genet., 2014 Nov;22:1330-3; Susswein LR et al. Genet. Med., 2016 Aug;18:823-32; Lagarde, A et al. J Med Genet 2010 Oct;47(10):721-2; Kim, B et al. BMC Med Genomics 2019 Jul;12(1):103). One publication showed this variant to have attenuated phenotype and to segregate with CRC (Ibrahim A et al. Eur. J. Hum. Genet., 2014 Nov;22:1330-3). In silico splice site analysis predicts that this alteration will result in the creation or strengthening of a novel splice acceptor site. RNA studies have demonstrated that this alteration results in an incomplete splice defect (Ambry internal data). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at